Pharmaceuticals & Biotech

Pipelines, trials, approvals, safety, manufacturing, and next‑gen therapies.

  • 7 Subtopics
  • 9 Tracked terms
  • Last 30 days Feed window
Search within this topic Ask AI about this topic All topics

Inside Pharmaceuticals & Biotech

Discovery & Preclinical Targets, assays, animal models, and early safety/tox studies before human trials. Clinical Trials (Phases I–IV) Design, endpoints, enrollment, interim reads, and post‑market surveillance. Approvals, Safety & REMS FDA/EMA decisions, boxed warnings, pharmacovigilance, and label changes. Generics & Biosimilars Access, interchangeability, litigation, and pricing dynamics for follow‑ons. Vaccines & Immunization Platforms (mRNA, viral vector), boosters, schedules, and cold‑chain supply. Cell & Gene Therapies CAR‑T, CRISPR, in vivo delivery, manufacturing, and long‑term follow‑up. Manufacturing & Supply APIs, sterile fill‑finish, shortages, and quality systems across the supply chain.

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Pharmaceuticals & Biotech


burgasmedia.com > amp > news > fentanil-e-otnel-zhivota-na-nad-100-dushi-v-balgariya-za-dve-godini-sochi-doklad-na-es

Fentanyl has killed more than 100 people in Bulgaria in two years, EU report says

6+ hour, 6+ min ago   (369+ words) Fentanyl deaths in Bulgaria are rising sharply, according to the EU Drugs Agency. A patient from Varna tells how he survived twice. Deaths from fentanyl in Bulgaria have risen sharply, according to the 2026 report of the European Union Drugs Agency....


nsw.gov.au > departments-and-agencies > wslhd > pulse > all-news > vaccination-collaboration

Collaboration at the heart of stronger immunisation outcomes

5+ day, 20+ hour ago   (394+ words) More than 100 health professionals, community representatives, consumers and partners came together to explore how we can strengthen immunisation uptake across Western Sydney. An Immunisation Workshop brought together representatives from 32 services across the District, including hospital and community health services, outreach…...


tradingview.com > news > reuters.com,2026:newsml_FWN45X03C:0-hlb-co-resubmits-new-drug-application-of-rivoceranib-to-us-fda

Hlb Co Resubmits New Drug Application Of Rivoceranib To Us FDA

51+ min ago   (23+ words) TradingView Hlb Co Resubmits New Drug Application Of Rivoceranib To Us FDA...


medium.com > @jh_simon > can-psychedelics-heal-a-narcissist-c3dcaa981d11

Can Psychedelics Heal A Narcissist?

1+ hour, 48+ min ago   (237+ words) The Case For Exploring New Approaches To Treating Narcissism When it comes to Cluster B personality disorders, DBT therapy is known as an effective treatment for … Can Psychedelics Heal A Narcissist? The Case For Exploring New Approaches To Treating Narcissism…...


insiderph.com > insider-info-ac-health-hires-ex-bumrungrad-ceo-as-new-investor-looms

INSIDER INFO | AC Health hires ex-Bumrungrad CEO as new investor looms

1+ hour, 22+ min ago   (321+ words) Dr. Num Tanthuwanit, the former CEO and medical director of Bangkok’s Bumrungrad International Hospital, has recently taken over as president and CEO of AC Health. His mandate: grow the business, modernize its operations and open new markets, including medical tourism....


dorsetecho.co.uk > news > 26625136.budmouth-students-raise-2-060-meningitis-now-charity

Budmouth students raise £2,060 for Meningitis Now charity

1+ hour, 12+ min ago   (841+ words) TWO students who were at the centre of a local meningitis outbreak have been praised after an incredible effort which has seen them give back to their community. Budmouth Academy students Freddy Whitehead, 15, and Jack Smith, 14, were among the young…...


medicaldialogues.in > pulmonology > news > dupilumab-may-improve-asthma-control-and-lung-function-in-chinese-patients-study-180276

Dupilumab may Improve Asthma Control and Lung Function in Chinese Patients: Study

9+ hour, 33+ min ago   (499+ words) Medical Dialogues...


pulse2.com > trigemx-bio-raises-94-million-to-advance-phase-3-migraine-program

TriGemX Bio Raises $94 Million To Advance Phase 3 Migraine Program

3+ hour, 28+ min ago   (328+ words) TriGemX Bio raised $94 million in financing co-led by The Column Group, TCGX, and Viking Global Investors to advance development of elismetrep, its investigational treatment for acute migraine. The company was formerly known as Kallyope and is relaunching under the TriGemX…...


medicalnewstoday.com > articles > healthy > pink-eye-covid

Is pink eye a symptom of COVID-19?

2+ hour, 20+ min ago   (739+ words) SARS-CoV-2 is the virus responsible for COVID-19. Individuals with COVID-19 may report a range of symptoms, which continues to grow as experts learn more about the illness. While it is not a common symptom, acquiring an infection with the SARS-CoV…...


ophthalmologytimes.com > view > aao-2026-mco-010-sustains-vision-gains-in-rp-through-4-years

AAO 2026: MCO-010 sustains vision gains in RP through 4 years

2+ hour, 13+ min ago   (353+ words) The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology Times, Modern Retina, Ophthalmology Times Europe, and Optometry Times. A single intravitreal injection of the optogenetic therapy sonpiretigene isteparvovec (MCO-010; Nanoscope…...